Selective targeting of multiple myeloma by B cell maturation antigen (BCMA)-specific central memory CD8+ cytotoxic T lymphocytes: immunotherapeutic application in vaccination and adoptive immunotherapy
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Selective targeting of multiple myeloma by B cell maturation antigen (BCMA)-specific central memory CD8+ cytotoxic T lymphocytes: immunotherapeutic application in vaccination and adoptive immunotherapy
Authors
Keywords
-
Journal
LEUKEMIA
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2019-03-14
DOI
10.1038/s41375-019-0414-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A phase I/Ib study of OTSGC-A24 combined peptide vaccine in advanced gastric cancer
- (2018) Raghav Sundar et al. BMC CANCER
- Investigational agents in immunotherapy: a new horizon for the treatment of multiple myeloma
- (2018) Cindy Varga et al. BRITISH JOURNAL OF HAEMATOLOGY
- Current developments in immunotherapy in the treatment of multiple myeloma
- (2018) Martin Köhler et al. CANCER
- Selective FcγR Co-engagement on APCs Modulates the Activity of Therapeutic Antibodies Targeting T Cell Antigens
- (2018) Jeremy D. Waight et al. CANCER CELL
- Present status and future perspective of peptide-based vaccine therapy for urological cancer
- (2018) Wataru Obara et al. CANCER SCIENCE
- Multiple Myeloma: Clinical Updates From the American Society of Hematology Annual Meeting, 2017
- (2018) Evangelos Terpos Clinical Lymphoma Myeloma & Leukemia
- The clinical significance of B-cell maturation antigen as a therapeutic target and biomarker
- (2018) Eric Sanchez et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Effective Targeting of Multiple B-Cell Maturation Antigen–Expressing Hematological Malignances by Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor T Cells
- (2018) Kevin M. Friedman et al. HUMAN GENE THERAPY
- In vivo antitumor function of tumor antigen-specific CTLs generated in the presence of OX40 co-stimulation in vitro
- (2018) Ngoc Pham Minh et al. INTERNATIONAL JOURNAL OF CANCER
- Histone deacetylase (HDAC) inhibitor ACY241 enhances anti-tumor activities of antigen-specific central memory cytotoxic T lymphocytes against multiple myeloma and solid tumors
- (2018) Jooeun Bae et al. LEUKEMIA
- Compromised functionality of monocyte-derived dendritic cells in multiple myeloma patients may limit their use in cancer immunotherapy
- (2018) Prajakta Shinde et al. Scientific Reports
- Approaches to Improve Chemically Defined Synthetic Peptide Vaccines
- (2018) Brett J. Hos et al. Frontiers in Immunology
- Blockade of LAG3 enhances responses of tumor-infiltrating T cells in mismatch repair-proficient liver metastases of colorectal cancer
- (2018) Guoying Zhou et al. OncoImmunology
- Assessment of Safety and Immunogenicity of PVX-410 Vaccine With or Without Lenalidomide in Patients With Smoldering Multiple Myeloma
- (2018) Ajay K. Nooka et al. JAMA Oncology
- Adoptive cell therapy in multiple Myeloma
- (2017) Sonia Vallet et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- LAG3 (CD223) as a cancer immunotherapy target
- (2017) Lawrence P. Andrews et al. IMMUNOLOGICAL REVIEWS
- Multiple therapeutic peptide vaccines for patients with advanced gastric cancer
- (2017) Yoshiyuki Fujiwara et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- DCOne as an Allogeneic Cell-based Vaccine for Multiple Myeloma
- (2017) Rebecca Karp Leaf et al. JOURNAL OF IMMUNOTHERAPY
- Identification and characterization of HLA-A24-specific XBP1, CD138 (Syndecan-1) and CS1 (SLAMF7) peptides inducing antigens-specific memory cytotoxic T lymphocytes targeting multiple myeloma
- (2017) J Bae et al. LEUKEMIA
- Management of relapsed and refractory multiple myeloma: novel agents, antibodies, immunotherapies and beyond
- (2017) C S Chim et al. LEUKEMIA
- The Role of B-Cell Maturation Antigen in the Biology and Management of, and as a Potential Therapeutic Target in, Multiple Myeloma
- (2017) Eric Sanchez et al. Targeted Oncology
- Agonist immunotherapy restores T cell function following MEK inhibition improving efficacy in breast cancer
- (2017) Sathana Dushyanthen et al. Nature Communications
- Plasma Levels of High-Mobility Group Box 1 during Peptide Vaccination in Patients with Recurrent Ovarian Cancer
- (2017) Kayoko Waki et al. Journal of Immunology Research
- Trial watch: Immune checkpoint blockers for cancer therapy
- (2017) Claire Vanpouille-Box et al. OncoImmunology
- T cells expressing an anti-B-cell maturation antigen chimeric antigen receptor cause remissions of multiple myeloma
- (2016) S. A. Ali et al. BLOOD
- Evaluation of B cell maturation antigen as a target for antibody drug conjugate mediated cytotoxicity in multiple myeloma
- (2016) Lydia Lee et al. BRITISH JOURNAL OF HAEMATOLOGY
- Cancer vaccines in colon and rectal cancer over the last decade: lessons learned and future directions
- (2016) John Berry et al. Expert Review of Clinical Immunology
- A novel BCMA/CD3 bispecific T-cell engager for the treatment of multiple myeloma induces selective lysis in vitro and in vivo
- (2016) S Hipp et al. LEUKEMIA
- APRIL, BCMA and TACI proteins are abnormally expressed in non-small cell lung cancer
- (2016) Hengli Dou et al. Oncology Letters
- Signaling Interplay between Bone Marrow Adipose Tissue and Multiple Myeloma cells
- (2016) Carolyne Falank et al. Frontiers in Endocrinology
- Vaccination of multiple myeloma: Current strategies and future prospects
- (2015) Alessandro Allegra et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Validity of combination active specific immunotherapy for colorectal cancer: a meta-analysis of 2993 patients
- (2015) Jun-Xia Cao et al. CYTOTHERAPY
- Immunotherapy for Multiple Myeloma, Past, Present, and Future: Monoclonal Antibodies, Vaccines, and Cellular Therapies
- (2015) Rebecca Karp Leaf et al. Current Hematologic Malignancy Reports
- Combination Immunotherapy after ASCT for Multiple Myeloma Using MAGE-A3/Poly-ICLC Immunizations Followed by Adoptive Transfer of Vaccine-Primed and Costimulated Autologous T Cells
- (2014) Aaron P. Rapoport et al. CLINICAL CANCER RESEARCH
- Immunotherapy Strategies in Multiple Myeloma
- (2014) Jooeun Bae et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- A multiepitope of XBP1, CD138 and CS1 peptides induces myeloma-specific cytotoxic T lymphocytes in T cells of smoldering myeloma patients
- (2014) J Bae et al. LEUKEMIA
- Mucin 1-specific active cancer immunotherapy with tecemotide (L-BLP25) in patients with multiple myeloma: An exploratory study
- (2014) Eva Rossmann et al. Human Vaccines & Immunotherapeutics
- B-cell Maturation Antigen Is a Promising Target for Adoptive T-cell Therapy of Multiple Myeloma
- (2013) R. O. Carpenter et al. CLINICAL CANCER RESEARCH
- Regulatory Roles of the Tumor Necrosis Factor Receptor BCMA
- (2013) Christine M. Coquery et al. CRITICAL REVIEWS IN IMMUNOLOGY
- A novel immunogenic CS1-specific peptide inducing antigen-specific cytotoxic T lymphocytes targeting multiple myeloma
- (2012) Jooeun Bae et al. BRITISH JOURNAL OF HAEMATOLOGY
- Myeloma-Specific Multiple Peptides Able to Generate Cytotoxic T Lymphocytes: A Potential Therapeutic Application in Multiple Myeloma and Other Plasma Cell Disorders
- (2012) J. Bae et al. CLINICAL CANCER RESEARCH
- Novel epitope evoking CD138 antigen-specific cytotoxic T lymphocytes targeting multiple myeloma and other plasma cell disorders
- (2011) Jooeun Bae et al. BRITISH JOURNAL OF HAEMATOLOGY
- Active-specific immunotherapy of human cancers with the heat shock protein Gp96-revisited
- (2011) Marco Randazzo et al. INTERNATIONAL JOURNAL OF CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search